Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

The Zacks Analyst Blog Highlights: Roche, Wells Fargo, General Electric, Microsoft and Intuit

researchsnappy by researchsnappy
December 12, 2020
in Investment Research
0
The Zacks Analyst Blog Highlights: Roche, Wells Fargo, General Electric, Microsoft and Intuit
399
SHARES
2.3k
VIEWS
Share on FacebookShare on Twitter

For Immediate Release

Chicago, IL – December 11, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Roche Holding AG RHHBY, Wells Fargo & Company WFC, General Electric Company GE, Microsoft Corporation MSFT and Intuit Inc. INTU.

Here are highlights from Thursday’s Analyst Blog:

Top Stock Reports for Roche, Wells Fargo and General Electric

The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Roche Holding, Wells Fargo and General Electric. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Shares of Roche have gained +12.6% over the past year against the Zacks Large Cap Pharmaceuticals industry’s increase of +7.8%. While the company’s sales in the first quarter were strong, the metric declined in the second quarter and again stabilized somewhat in the third. The Zacks analyst believes that although growth in Ocrevus, Perjeta, Tecentriq and Hemlibra maintained momentum, COVID-19 disruptions and biosimilar competition for Herceptin, MabThera and Avastin weighed on the solid performances.

Nevertheless, the Diagnostics division was boosted by the launch of diagnostic products for COVID-19 and should sustain this uptrend in the next few quarters. Label expansion of Tecentriq into additional indications is a positive and should surge sales.

(You can read the full research report on Roche here >>>)

Wells Fargo shares have underperformed the Zacks Banks – Major Regional industry in the year to date period (-46.0% vs. -21.3%). The Zacks analyst believes that Wells Fargo’s revenues remain under pressure due to low interest rates and a volatile fee income trend. Also, rising expenses in providing benefits to clients amid coronavirus concerns might curb bottom-line growth. Legal hassles also remain a concern.

Nevertheless, the company’s efforts to enhance compliance and risk-management capability, along with streamlining activities seem encouraging. Also, strong loans and deposits balance depicts robust capital position. Moreover, given a strong liquidity position, the company carries less credit risk in case of any economic downturn. Improving credit quality remains a tailwind.

(You can read the full research report on Wells Fargo here >>>)

General Electric shares have outperformed the Zacks Diversified Operations industry over the past three-month period (+91.4% vs. +23.3%). The Zacks analyst believes that the company is poised to gain from its portfolio-restructuring program, expansion in digital business, efforts to deleverage balance sheet and solid liquidity position in the quarters ahead.

However, the pandemic-related market challenges — especially for Healthcare, Aviation and Power — related to the pandemic remain concerning. Its measures to deal with the pandemic might be a relief. In addition, forex woes might hurt in the quarters ahead.

(You can read the full research report on General Electric here >>>)

Other noteworthy reports we are featuring today include Microsoft and Intuit.

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.4% per year.
These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

[email protected]                                      

https://www.zacks.com                                          

 

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Microsoft Corporation (MSFT): Free Stock Analysis Report
 
Roche Holding AG (RHHBY): Free Stock Analysis Report
 
Intuit Inc. (INTU): Free Stock Analysis Report
 
Wells Fargo & Company (WFC): Free Stock Analysis Report
 
General Electric Company (GE): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Previous Post

Meticore Reviews: Latest Consumer Report and Research Data by Wholesomealive – Online Free Press release news distribution

Next Post

Magnetic resonance imaging-based partial volume-corrected 18F-sodium fluoride positron emission tomography in the femoral neck

Next Post
Hip Arthroscopy for Femoroacetabular Impingement: 1-Year Outcomes Predict 5-Year Outcomes

Magnetic resonance imaging-based partial volume-corrected 18F-sodium fluoride positron emission tomography in the femoral neck

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News
  • Top Company News

HPIN International Financial Platform Becomes a New Benchmark for India’s Digital Economy

Top 10 Market Research Companies in the world

3 Best Market Research Certifications in High Demand

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2025 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2025 researchsnappy.com